Myriad Genetics, Inc. (MYGN)

Myriad Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	145.4	102.4	132.1	56.9	257.4	117
Short-Term Investments	-	-	8.8	58	81.4	33.7
Cash & Short-Term Investments	145.4	102.4	140.9	114.9	338.8	150.7
Cash Growth	45.55%	-27.32%	22.63%	-66.09%	124.82%	-30.81%
Accounts Receivable	118	121.2	114.3	101.6	91.3	89.5
Receivables	118	121.2	114.3	101.6	91.3	89.5
Inventory	31.6	27.5	22	20.1	15.3	27.1
Prepaid Expenses	49.8	38.3	35.2	36	39.4	122.1
Restricted Cash	-	8.6	1.2	2	-	-
Total Current Assets	344.8	298	313.6	274.6	484.8	389.4
Property, Plant & Equipment	162	172.4	180.6	187.3	125.3	100.4
Long-Term Investments	-	-	-	54.8	59	21
Goodwill	51.6	286.3	287.4	286.8	239.2	329.2
Other Intangible Assets	163.1	265.8	354.1	386.8	410.8	578.8
Other Long-Term Assets	6.6	5.1	10.8	8.4	1.6	-
Total Assets	728.1	1,028	1,147	1,199	1,321	1,419
Accounts Payable	31.8	32.3	25.8	28.8	29.6	20.5
Accrued Expenses	77.2	79.9	75.7	70.2	82.7	62.1
Current Portion of Leases	7.9	12.8	16.2	14.1	13	13.6
Current Income Taxes Payable	5.1	5.1	4.6	4.8	4	4.3
Current Unearned Revenue	-	-	-	-	-	32.7
Other Current Liabilities	26	34	33.6	19.3	75	12.7
Total Current Liabilities	148	164.1	155.9	137.2	204.3	145.9
Long-Term Debt	119.5	39.6	38.5	-	-	224.8
Long-Term Leases	84.9	87.9	97.4	130.9	79.3	50.6
Long-Term Deferred Tax Liabilities	-	-	-	-	35.8	71.3
Other Long-Term Liabilities	2.9	34.9	71.5	44.8	33.5	45.2
Total Liabilities	355.3	326.5	363.3	312.9	352.9	537.8
Common Stock	0.9	0.9	0.9	0.8	0.8	0.8
Additional Paid-In Capital	1,487	1,458	1,416	1,260	1,226	1,110
Retained Earnings	-1,115	-756.8	-629.5	-366.2	-254.2	-227
Comprehensive Income & Other	-0.1	-0.8	-3.7	-8.9	-5.1	-2.3
Total Common Equity	372.8	701.1	783.2	885.8	967.8	881
Shareholders' Equity	372.8	701.1	783.2	885.8	967.8	881
Total Liabilities & Equity	728.1	1,028	1,147	1,199	1,321	1,419
Total Debt	212.3	140.3	152.1	145	92.3	289
Net Cash (Debt)	-66.9	-37.9	-11.2	24.7	305.5	-117.3
Net Cash Growth	-	-	-	-91.92%	-	-
Net Cash Per Share	-0.73	-0.42	-0.14	0.31	3.92	-1.57
Filing Date Shares Outstanding	93.21	91.31	89.87	81.22	80.02	76.3
Total Common Shares Outstanding	93.1	91.3	89.9	81.2	80	75.4
Working Capital	196.8	133.9	157.7	137.4	280.5	243.5
Book Value Per Share	4.00	7.68	8.71	10.91	12.10	11.68
Tangible Book Value	158.1	149	141.7	212.2	317.8	-27
Tangible Book Value Per Share	1.70	1.63	1.58	2.61	3.97	-0.36
Machinery	114.9	148.5	147.6	124.7	112.4	117.9
Leasehold Improvements	79.8	78.5	91.3	67.9	38	35.7

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q